Feasibility of Introducing an Onsite Test for Syphilis in the Package of Antenatal Care in Burkina Faso
Feasibility of Introducing an Onsite Test for Syphilis in the Package of Antenatal Care at the Rural Primary Health Care Level in Burkina Faso
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- pregnant woman aged 18 and over at first antenatal care visit
- pregnant woman who gave consent for receiving rapid diagnosis test
Exclusion Criteria:
- Pregnant woman aged less than 18 years
- Pregnant woman not at their first antenatal care visit
- Pregnant woman who did not give her consent for receiving rapid diagnosis test
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pregnant women who were screened for syphilis
Time Frame: may 2013 to september 2013
|
Number of pregnant women who received rapid diagnostic test for syphilis
|
may 2013 to september 2013
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Seni KOUANDA, PhD, Insitut de Recherche en Science de la santé
- Study Director: Fadima YAYA BOCOUM, PhD, Insitut de Recherche en Science de la santé
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IRSS003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diagnoses Disease
-
NCT06439901RecruitingDiagnoses Disease | Bronchopulmonary Disease
-
NCT04743843Completed
-
NCT04497233Unknown
-
NCT05876429CompletedInpatient Facililty Diagnoses
-
NCT04648579CompletedInpatient Facililty Diagnoses
-
NCT03730493Completed
-
NCT01547650UnknownOther Diagnoses and Conditions
Clinical Trials on Feasibility of introducing onsite test for syphilis in the package of antenatal care at rural primary health care in Burkina Faso
-
NCT06469788RecruitingAutoimmune Diseases | Rheumatologic Disease
-
NCT05680714Active, not recruitingHip Fractures | Fall Injury
-
NCT00984399CompletedBreast Cancer | Atrophic Vaginitis
-
NCT07347652Active, not recruitingDVT Prophylaxis | DVT - Deep Vein Thrombosis | Cardiac On-pump Surgery | DVT Prevention | On-pump Cardiac Surgery - Prevention - Intervention - Experimental Group - Control Group - Incidence - Complications | Nursing Care Protocol
-
NCT05639556Active, not recruiting